Private equity has acquired hundreds of ophthalmology practices over the past several years, consolidating marketing budgets, data science teams, and bidding algorithms into a handful of well-capitalized groups. When one of these groups enters your local Facebook or Google ad auction, the cost-per-lead floor rises — and it tends to stay there.

That’s the bad news. The good news is that PE-backed groups win by scale and bid discipline, not by being smarter about who they’re targeting. That gap is exactly where independent practices can still compete — and in some cases, win outright.

Go upstream of the auction entirely. PE-backed groups bid aggressively on people already searching “cataract surgery near me.” Independent practices can reach people before they identify as a patient — when they’re still framing vision decline as just getting older. There’s no bidding war for an audience that isn’t searching yet.

Own a niche the algorithm hasn’t priced in. Centralized marketing teams optimize for broad, high-volume audiences across many locations. A specific niche — a sport, a profession, a hobby — is rarely worth their time to build custom creative around. That niche is wide open for a single local practice to own completely.

Compete on trust, not impressions. The vast majority of patients who get surgery go with the first practice that diagnosed their need. Education-first content that builds authority before the sale converts at a different rate than a retargeting ad — and it’s nearly impossible for a centralized, multi-location brand to replicate locally.

Move faster than a committee can approve. PE-backed groups route creative and targeting decisions through layers of approval across many locations. An independent practice can test a new audience, message, or offer in days. Speed is a real advantage — most practices just aren’t using it.

None of this requires matching a consolidator’s ad budget. It requires competing somewhere their playbook doesn’t reach. The practices losing ground to PE-backed chains aren’t losing because their care is worse — they’re losing because they’re fighting for the same in-market patients, in the same auction, with a fraction of the budget. The practices holding ground are the ones who found a patient population the consolidators aren’t built to reach, and got there first.